5 takeaways from AP’s report on the big backlog of uninspected drug factories
WASHINGTON -- As COVID-19 swept across the globe in early 2020, the Food and Drug Administration pulled most of its safety inspectors from the field, creating a massive backlog of uninspected pharmaceutical plants in the…
